Serotonin Enhances Megakaryopoiesis and Proplatelet Formation via p-Erk1/2 and F-Actin Reorganization

Citations Over TimeTop 14% of 2014 papers

Abstract

Our previous studies have shown that serotonin (5-hydroxytryptamine; 5-HT) is a growth factor for hematopoietic stem/progenitor cells. In this study, we proposed a possible mechanism: 5-HT may enhance megakaryopoiesis and proplatelet formation via Erk1/2 pathway and cytoskeleton reorganization. Here, 5-HT(2B)R was first identified in megakaryocytic cells. 5-HT also promoted the megakaryocytes (MKs) proliferation and reduced the cell apoptosis via the activation of 5-HT(2B)R and Akt pathway. The effects were reduced by the 5-HT2B R inhibitor ketanserin. The effect of 5-HT on proplatelet formation in bone marrow MKs were further confirmed: the 5-HT treated group had more proplatelet bearing MKs compared with the control group. To determine whether 5-HT has effects on cytoskeleton reorganization of MKs, and whether these effects could be reduced by ketanserin or Erk1/2 inhibitor PD98059, MKs were stained with the F-actin specific binder rhodamine-phalloidin. The polymerized actin level was lower in the control group than the 5-HT group and was distributed throughout the cytoplasm with occasional aggregations. Our data demonstrated that Erk1/2 was activated in MKs treated with 5-HT. This study suggests that 5-HT has a potent effect on platelet formation and this effect is likely mediated via 5HT(2B)R with subsequent activation of p-Erk1/2 and consequent F-actin reorganization and proplatelet formation. We also demonstrated that melatonin, the metabolite of 5-HT, exerts a protective effect on MK and platelet recovery in the irradiated mouse model. This study suggested that 5-HT plays an important role in platelet formation via 5HT(2B)R, p-Erk1/2, and F-actin reorganization.

Related Papers

• → Participation of 5‐HT₁‐like and 5‐HT_2A receptors in the contraction of human temporal artery by 5‐hydroxytryptamine and related drugs(1996)28 cited
• → Antihypertensive Action and Serotonin-Induced Platelet Aggregation During Long-Term Ketanserin Treatment in Hypertensive Patients(1984)36 cited
• → Experience With Ketanserin, A Serotonin (S₂) Antagonist, in Longterm Treatment of Essential Hypertension(1984)11 cited
• → 5-Hydroxytryptamine induces contraction in isolated human mammary artery: Effect of ketanserin(1990)1 cited
• [Effect of ketanserin on various properties of pentobarbital in rats].(1983)